373 related articles for article (PubMed ID: 31580915)
1. Dopamine and norepinephrine transporter inhibition for long-term fear memory enhancement.
Pantoni MM; Carmack SA; Hammam L; Anagnostaras SG
Behav Brain Res; 2020 Jan; 378():112266. PubMed ID: 31580915
[TBL] [Abstract][Full Text] [Related]
2. Animal model of methylphenidate's long-term memory-enhancing effects.
Carmack SA; Howell KK; Rasaei K; Reas ET; Anagnostaras SG
Learn Mem; 2014 Jan; 21(2):82-9. PubMed ID: 24434869
[TBL] [Abstract][Full Text] [Related]
3. Age-related changes in prefrontal norepinephrine transporter density: The basis for improved cognitive flexibility after low doses of atomoxetine in adolescent rats.
Bradshaw SE; Agster KL; Waterhouse BD; McGaughy JA
Brain Res; 2016 Jun; 1641(Pt B):245-57. PubMed ID: 26774596
[TBL] [Abstract][Full Text] [Related]
4. Norepinephrine transporter blockade can normalize the prepulse inhibition deficits found in dopamine transporter knockout mice.
Yamashita M; Fukushima S; Shen HW; Hall FS; Uhl GR; Numachi Y; Kobayashi H; Sora I
Neuropsychopharmacology; 2006 Oct; 31(10):2132-9. PubMed ID: 16407898
[TBL] [Abstract][Full Text] [Related]
5. Neurokinin-1 Antagonism Distinguishes the Role of Norepinephrine Transporter from Dopamine Transporter in Mediating Amphetamine Behaviors.
Mannangatti P; Ragu Varman D; Ramamoorthy S; Jayanthi LD
Pharmacology; 2021; 106(11-12):597-605. PubMed ID: 34515205
[TBL] [Abstract][Full Text] [Related]
6. Dissociations between cognitive and motor effects of psychostimulants and atomoxetine in hyperactive DAT-KO mice.
Del'Guidice T; Lemasson M; Etiévant A; Manta S; Magno LA; Escoffier G; Roman FS; Beaulieu JM
Psychopharmacology (Berl); 2014 Jan; 231(1):109-22. PubMed ID: 23912772
[TBL] [Abstract][Full Text] [Related]
7. Acute blockade of the Caenorhabditis elegans dopamine transporter DAT-1 by the mammalian norepinephrine transporter inhibitor nisoxetine reveals the influence of genetic modifications of dopamine signaling in vivo.
Bermingham DP; Hardaway JA; Snarrenberg CL; Robinson SB; Folkes OM; Salimando GJ; Jinnah H; Blakely RD
Neurochem Int; 2016 Sep; 98():122-8. PubMed ID: 26850478
[TBL] [Abstract][Full Text] [Related]
8. Cortico-subcortical neuromodulation involved in the amelioration of prepulse inhibition deficits in dopamine transporter knockout mice.
Arime Y; Kasahara Y; Hall FS; Uhl GR; Sora I
Neuropsychopharmacology; 2012 Oct; 37(11):2522-30. PubMed ID: 22781838
[TBL] [Abstract][Full Text] [Related]
9. Gain of function mutants reveal sites important for the interaction of the atypical inhibitors benztropine and bupropion with monoamine transporters.
Mortensen OV; Amara SG
J Neurochem; 2006 Sep; 98(5):1531-40. PubMed ID: 16923164
[TBL] [Abstract][Full Text] [Related]
10. Psychostimulant-like discriminative stimulus and locomotor sensitization properties of the wake-promoting agent modafinil in rodents.
Paterson NE; Fedolak A; Olivier B; Hanania T; Ghavami A; Caldarone B
Pharmacol Biochem Behav; 2010 Jun; 95(4):449-56. PubMed ID: 20346966
[TBL] [Abstract][Full Text] [Related]
11. Deconstructed Analogues of Bupropion Reveal Structural Requirements for Transporter Inhibition versus Substrate-Induced Neurotransmitter Release.
Shalabi AR; Walther D; Baumann MH; Glennon RA
ACS Chem Neurosci; 2017 Jun; 8(6):1397-1403. PubMed ID: 28220701
[TBL] [Abstract][Full Text] [Related]
12. Dopamine uptake through the norepinephrine transporter in brain regions with low levels of the dopamine transporter: evidence from knock-out mouse lines.
Morón JA; Brockington A; Wise RA; Rocha BA; Hope BT
J Neurosci; 2002 Jan; 22(2):389-95. PubMed ID: 11784783
[TBL] [Abstract][Full Text] [Related]
13. Cocaine mechanisms: enhanced cocaine, fluoxetine and nisoxetine place preferences following monoamine transporter deletions.
Hall FS; Li XF; Sora I; Xu F; Caron M; Lesch KP; Murphy DL; Uhl GR
Neuroscience; 2002; 115(1):153-61. PubMed ID: 12401330
[TBL] [Abstract][Full Text] [Related]
14. Effects of Atomoxetine on Motor and Cognitive Behaviors and Brain Electrophysiological Activity of Dopamine Transporter Knockout Rats.
Ptukha M; Fesenko Z; Belskaya A; Gromova A; Pelevin A; Kurzina N; Gainetdinov RR; Volnova A
Biomolecules; 2022 Oct; 12(10):. PubMed ID: 36291693
[TBL] [Abstract][Full Text] [Related]
15. The effects of methylphenidate on knockin mice with a methylphenidate-resistant dopamine transporter.
Tilley MR; Gu HH
J Pharmacol Exp Ther; 2008 Nov; 327(2):554-60. PubMed ID: 18698001
[TBL] [Abstract][Full Text] [Related]
16. Role of serotonin in the paradoxical calming effect of psychostimulants on hyperactivity.
Gainetdinov RR; Wetsel WC; Jones SR; Levin ED; Jaber M; Caron MG
Science; 1999 Jan; 283(5400):397-401. PubMed ID: 9888856
[TBL] [Abstract][Full Text] [Related]
17. Adolescent atomoxetine treatment in a rodent model of ADHD: effects on cocaine self-administration and dopamine transporters in frontostriatal regions.
Somkuwar SS; Jordan CJ; Kantak KM; Dwoskin LP
Neuropsychopharmacology; 2013 Dec; 38(13):2588-97. PubMed ID: 23822950
[TBL] [Abstract][Full Text] [Related]
18. Animal models of depression in dopamine, serotonin, and norepinephrine transporter knockout mice: prominent effects of dopamine transporter deletions.
Perona MT; Waters S; Hall FS; Sora I; Lesch KP; Murphy DL; Caron M; Uhl GR
Behav Pharmacol; 2008 Sep; 19(5-6):566-74. PubMed ID: 18690111
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of dopamine and norepinephrine reuptake produces additive effects on energy balance in lean and obese mice.
Billes SK; Cowley MA
Neuropsychopharmacology; 2007 Apr; 32(4):822-34. PubMed ID: 16841072
[TBL] [Abstract][Full Text] [Related]
20. Memory and psychostimulants: modulation of Pavlovian fear conditioning by amphetamine in C57BL/6 mice.
Wood SC; Anagnostaras SG
Psychopharmacology (Berl); 2009 Jan; 202(1-3):197-206. PubMed ID: 18478205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
